Results 181 to 190 of about 12,690 (238)
Rethinking Equine Cystitis: Evidence from Four Atypical Clinical Presentations. [PDF]
Biazik A +4 more
europepmc +1 more source
Radiodynamic Therapy Using Local Administration of 5-Aminolevulinic Acid for <i>In Vivo</i> Osteosarcoma Xenograft Model. [PDF]
Tanemura Y +6 more
europepmc +1 more source
Randomised clinical trial comparing intramuscular alfaxalone and butorphanol sedation with or without midazolam in hyperthyroid cats. [PDF]
Deutsch J +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drug and Alcohol Dependence, 1985
Butorphanol (Stadol) is a synthetic agonist-antagonist analgesic from the 14-hydroxymorphinan series. Animal studies display analgesia, antitussive effects, low gastrointestinal activity, limited respiratory depression, some cardiovascular and skeletal muscle actions, diuresis, slight miosis and opiate antagonism.
I J, Pachter, R P, Evens
openaire +2 more sources
Butorphanol (Stadol) is a synthetic agonist-antagonist analgesic from the 14-hydroxymorphinan series. Animal studies display analgesia, antitussive effects, low gastrointestinal activity, limited respiratory depression, some cardiovascular and skeletal muscle actions, diuresis, slight miosis and opiate antagonism.
I J, Pachter, R P, Evens
openaire +2 more sources
Journal of the American Animal Hospital Association, 1998
Ten ferrets were used in a crossover study to determine the sedative effects of intramuscularly (IM) administered diazepam (3 mg/kg body weight)-butorphanol (0.2 mg/kg body weight), acepromazine (0.1 mg/kg body weight)-butorphanol (0.2 mg/kg body weight), or xylazine (2.0 mg/kg body weight)-butorphanol (0.2 mg/kg body weight).
J C, Ko +3 more
openaire +2 more sources
Ten ferrets were used in a crossover study to determine the sedative effects of intramuscularly (IM) administered diazepam (3 mg/kg body weight)-butorphanol (0.2 mg/kg body weight), acepromazine (0.1 mg/kg body weight)-butorphanol (0.2 mg/kg body weight), or xylazine (2.0 mg/kg body weight)-butorphanol (0.2 mg/kg body weight).
J C, Ko +3 more
openaire +2 more sources
Efficacy of caudal butorphanol
The Indian Journal of Pediatrics, 2006To evaluate the efficacy of butorphanol with or without bupivacaine for caudal epidural anesthesia in children undergoing infraumbilical surgery.Sixty ASA physical status I and II patients of either sex aged 1-10 yr were randomized to one of three groups.
Vinita, Singh +2 more
openaire +2 more sources
Human Perinatal Distribution of Butorphanol
Obstetric Anesthesia Digest, 1980The perinatal distribution of butorphanol was demonstrated in relation to maternal-neonatal transfer and colostrum/milk excretion in obstetric patients. Parenteral butorphanol passed the placental barrier and was found in neonatal cord serum.
K A, Pittman +5 more
openaire +2 more sources
Journal of the American Animal Hospital Association, 1998
Ten ferrets were used in a crossover study to determine the sedative effects of intramuscularly administered diazepam (3 mg/kg body weight)-butorphanol (0.2 mg/kg body weight)-ketamine (15 mg/kg body weight); acepromazine (0.1 mg/kg body weight)-butorphanol (0.2 mg/kg body weight)-ketamine (15 mg/kg body weight); and xylazine (2 mg/kg body weight ...
J C, Ko +3 more
openaire +2 more sources
Ten ferrets were used in a crossover study to determine the sedative effects of intramuscularly administered diazepam (3 mg/kg body weight)-butorphanol (0.2 mg/kg body weight)-ketamine (15 mg/kg body weight); acepromazine (0.1 mg/kg body weight)-butorphanol (0.2 mg/kg body weight)-ketamine (15 mg/kg body weight); and xylazine (2 mg/kg body weight ...
J C, Ko +3 more
openaire +2 more sources

